Research study Program year 2025 Source: CMS Open Payments

Phase Iiib, Observer-Blind, Randomized, Placebo-Controlled, Multi-Cent

Research payments

$5,276,458

1,494 payments

Through program year 2025, $5,276,458 in research payments was reported against Phase Iiib, Observer-Blind, Randomized, Placebo-Controlled, Multi-Cent, across 1,494 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$62,413	26
2024	Research	$165,619	89
2023	Research	$3,099,987	667
2022	Research	$951,156	366
2021	Research	$40,679	17
2020	Research	$956,604	329

Breakdown

Who paid Research payments · program years 2020–2025

GlaxoSmithKline, LLC. $5,276,458 1,494 payments

Who received the money Research payments · program years 2020–2025

Kaiser Foundation Research Institute Organisation paid for research $629,866 85 payments
Pas Research Organisation paid for research $443,763 55 payments
Johnson County Clintrials Organisation paid for research $382,850 4 payments
Brcr Medical Center INC Organisation paid for research $318,848 46 payments
Pharmaceutical Research Organizatio Organisation paid for research $245,203 149 payments
Meridian Clinical Research LLC Organisation paid for research $215,568 34 payments
New Orleans Center For Clinical Research Organisation paid for research $209,470 53 payments
Kaiser Foundation Research Institute A Division Of Kaiser Foundation Hospitals Organisation paid for research $187,344 28 payments
Pharmaceutical Research Org Organisation paid for research $147,854 36 payments
Tekton Research LLC Organisation paid for research $119,807 34 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.